We are pleased to invite you to read the most viewed papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Cancer Biomarkers”. The list of papers is as follows:

“Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings”
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

“Effect of Selenium and Lycopene on Radiation Sensitivity in Prostate Cancer Patients Relative to Controls”
by Varinderpal S. Dhillon, Permal Deo and Michael Fenech
Cancers 2023, 15(3), 979; https://doi.org/10.3390/cancers15030979
Available online: https://www.mdpi.com/2072-6694/15/3/979

“Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors”
by Yasuyuki Matsumoto and Tongzhong Ju
Cancers 2023, 15(14), 3536; https://doi.org/10.3390/cancers15143536
Available online: https://www.mdpi.com/2072-6694/15/14/3536

“Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1”
by Jessica M. Logan, Ashley M. Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R. D. Johnson, Shane M. Hickey, Ben S.-Y. Ung et al.
Cancers 2023, 15(12), 3215; https://doi.org/10.3390/cancers15123215
Available online: https://www.mdpi.com/2072-6694/15/12/3215

“Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data”
by Katrin S. Kurz, Sabrina Kalmbach, Michaela Ott, Annette M. Staiger, German Ott and Heike Horn
Cancers 2023, 15(3), 785; https://doi.org/10.3390/cancers15030785
Available online: https://www.mdpi.com/2072-6694/15/3/785

“Mucins as Potential Biomarkers for Early Detection of Cancer”
by Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser and Maneesh Jain
Cancers 2023, 15(6), 1640; https://doi.org/10.3390/cancers15061640
Available online: https://www.mdpi.com/2072-6694/15/6/1640

“LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer”
by Shuaibu Nazifi Sani, Wei Zhou, Balarabe B. Ismail, Yongkui Zhang, Zhijun Chen, Binjie Zhang, Changqian Bao, Houde Zhang and Xiaozhi Wang
Cancers 2023, 15(4), 1186; https://doi.org/10.3390/cancers15041186
Available online: https://www.mdpi.com/2072-6694/15/4/1186

“Liquid Biopsies, Novel Approaches and Future Directions”
by Athanasios Armakolas, Maria Kotsari and John Koskinas
Cancers 2023, 15(5), 1579; https://doi.org/10.3390/cancers15051579
Available online: https://www.mdpi.com/2072-6694/15/5/1579

“Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma”
by Gabriele Perrone, Luigi Rigacci, Sara Urru, Sofya Kovalchuk, Marco Brugia, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo et al.
Cancers 2023, 15(10), 2753; https://doi.org/10.3390/cancers15102753
Available online: https://www.mdpi.com/2072-6694/15/10/2753

“Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer”
by Helena Čelešnik and Uroš Potočnik
Cancers 2023, 15(4), 1087; https://doi.org/10.3390/cancers15041087
Available online: https://www.mdpi.com/2072-6694/15/4/1087

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office